Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Figs Inc (FIGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Figs Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Figs Inc trades at $15 (market cap $2.34B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2× Figs Inc's market cap, and Figs Inc is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Figs Inc for 33 Days on average.
| DFTX | FIGS | |
|---|---|---|
Market Cap | $4.71B | $2.34B |
Volume | 1,966,636 | 6,865,366 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $17.12 |
52-Week Low | $10.68 | $6.90 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $3.67B | $2.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FIGS stock trades at $14.98, up 6.24% today, with strong technical momentum and bullish moving averages. The company shows accelerating revenue growth, with 2025 revenue reaching $631.10M and net income of $34.25M. Recent earnings beats and raised 2026 guidance signal operational strength, though valuation multiples remain elevated with a P/E of 42.61. International expansion continues to drive growth, with Q2 international sales surging 67%.
The outlook remains positive with analyst consensus pointing to 26.4% upside potential to $18.00 target. Strong fundamentals and momentum are balanced by rich valuation requiring continued execution. Key risks include premium pricing pressure and competitive threats in healthcare apparel. Wall Street sentiment leans bullish with 60% buy ratings among 15 analysts covering the stock.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →
